ANTI-INFLAMMATORY EFFECTS OF OMEGA-3 FATTY ACID SUPPLEMENTATION ON ATHEROSCLEROTIC PLAQUES IN PATIENTS.

In a recent clinical trial, supplementary fish oil containing omega-3 fatty acids was given to patients for a median time of 3 weeks (up to 7 weeks) prior to surgical removal of their advanced carotid atherosclerotic plaques. Inflammatory activities associated with such plaques are known to lead to their instability, tendency to rupture, and serious cardiovascular outcomes. In this trial, 60 patients in each group were supplemented daily with a placebo (olive oil) or 2 grams/day of omega-3 fatty acids as DHA and EPA. Examinations of the removed plaques and analyses showed significantly lessened inflammation and histology scores in the omega-3 group as compared to the placebo group. Inflammatory factors including foam cells, macrophages, T-cells, and pro-inflammatory biochemical mediators including matrix metalloproteinases and intercellular adhesion molecule were significantly lower in the omega-3 group. Dr. Calder indicated that these decreased inflammatory responses seen in the plaques of patients receiving DHA/EPA supplementation may play a role in decreasing cardiovascular events associated with plaque instability. (NPICenter.com, 07/27/06)